Allstate Investment Management’s Elevance Health ELV Stock Holding History

Allstate Investment Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$5.35M	Buy	+10,433	New	+$5.3M	0.16%	88

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Allstate Investment Management's ELV Position: Q4 2022 in Review

Allstate Investment Management opened a new position in Elevance Health (ELV) in Q4 2022: 10,433 shares worth $5.35M. The stake represents 0.16% of the portfolio and ranks #88 among its holdings.

1,548 funds tracked by Wall St. Rank hold ELV as of Q4 2022.

Allstate Investment Management held 10,433 shares of Elevance Health worth $5.35M as of Q4 2022.
Elevance Health was a new Allstate Investment Management position in Q4 2022.
Elevance Health made up 0.16% of Allstate Investment Management's portfolio in Q4 2022, its #88 holding.
1,548 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.

Based on Allstate Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.